Regulatory Activity in Two States Restricts How Plans Structure Specialty Drug Coverage

Two state insurance regulators, Florida and Montana, have taken recent regulatory action to address ...
Uncategorized
discriminatory benefit design, nondiscrimination, specialty tier drugs, State of the States